Mission
Our background
Our background
Targeted nuclide therapy
Candidates and pipeline
RLT with our portfolio
Clinical results
Five assets
Contact
Contact
Imprint
Privacy
Yukon has a pipeline of five assets around PP-F11N
1) Further radionuclides in discussion
(c) Copyright 2024 Yukon Biosciences, Ltd.
